As of Oct 26
| -0.08 / -2.61%|
The 4 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 3.63, with a high estimate of 5.00 and a low estimate of 2.75. The median estimate represents a +21.64% increase from the last price of 2.98.
The current consensus among 4 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.